The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer
Official Title: A Phase II Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer
Study ID: NCT00055419
Brief Summary: The purpose of this clinical research study is to learn about the safety of cetuximab in patients with stage IV colorectal cancer, and who may benefit from cetuximab.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
ImClone Investigational Site, Bakersfield, California, United States
ImClone Investigational Site, Los Angeles, California, United States
ImClone Investigational Site, Denver, Colorado, United States
ImClone Investigational Site, Torrington, Connecticut, United States
ImClone Investigational Site, Washington, District of Columbia, United States
ImClone Investigational Site, Jacksonville, Florida, United States
ImClone Investigational Site, Miami, Florida, United States
ImClone Investigational Site, Orlando, Florida, United States
ImClone Investigational Site, Atlanta, Georgia, United States
ImClone Investigational Site, Decatur, Illinois, United States
ImClone Investigational Site, Louisville, Kentucky, United States
ImClone Investigational Site, New Orleans, Louisiana, United States
ImClone Investigational Site, Baltimore, Maryland, United States
ImClone Investigational Site, Ypsilanti, Michigan, United States
ImClone Investigational Site, Minneapolis, Minnesota, United States
ImClone Investigational Site, St Charles, Missouri, United States
ImClone Investigational Site, Great Falls, Montana, United States
ImClone Investigational Site, Las Vegas, Nevada, United States
ImClone Investigational Site, Voorhees, New Jersey, United States
ImClone Investigational Site, East Setauket, New York, United States
ImClone Investigational Site, Latham, New York, United States
ImClone Investigational Site, New York City, New York, United States
ImClone Investigational Site, Cleveland, Ohio, United States
ImClone Investigational Site, Portland, Oregon, United States
ImClone Investigational Site, Greenville, South Carolina, United States
ImClone Investigational Site, Memphis, Tennessee, United States
ImClone Investigational Site, Dallas, Texas, United States
ImClone Investigational Site, Norfolk, Virginia, United States
ImClone Investigational Site, Green Bay, Wisconsin, United States
Name: E-mail: ClinicalTrials@ ImClone.com
Affiliation: Eli Lilly and Company
Role: STUDY_CHAIR